Highlights

Virtual Presentations

Selected virtual presentations from the ENDO 2021 Virtual Meeting

 

 
 
 

Thyroid Nodule: Whack It, Zap It, or Leave It Alone?

Case Presenter: Sana Ghaznavi, MD
Moderator: Michael Tuttle, MD

Panelists:
Mary C Frates, MD
Marius N Stan, MD
Chienying Liu, MD
Julie Ann Sosa, MD, MA

 
 
 
 

Clinical Advances in Pituitary Diseases

Chair: Shlomo Melmed, MB ChB

  • Osilodrostat Is an Effective and Well-Tolerated Treatment for Cushing's Disease (CD): Results From a Phase III Study With an Upfront, Randomized, Double-Blind, Placebo-Controlled Phase (LINC 4)
    Mônica Gadelha, MD, PhD
     
  • Metyrapone Treatment in Endogenous Cushing’s Syndrome: Results at Week 12 From PROMPT, a Prospective International Multicenter, Open-Label, Phase III/IV Study
    Lynnette K Nieman, MD
     
  • One-Year Outcomes of the Open-Label Extension of CHIASMA OPTIMAL, a Phase 3 Study of Oral Octreotide Capsules in Acromegaly
    Susan Leanne Samson, MD, PhD
     
  • GLP1 Receptor Agonists Reduce Fluid Intake in Primary Polydipsia
    Bettina Felicitas Winzeler, MD
 
 
 
 

Transgender Care: A Comprehensive Assessment for a Multi-Faceted Condition

Chair: Stephen M Rosenthal, MD

  • Psychosocial Assessment: A Key Component in the Care to Transgender Youth 89
    Thomas D Steensma, PhD
     
  • Hormonal Management of Gender Dysphoria in Adolescents
    Sabine E Hannema, MD, PhD
     
  • Transition of Care for Transgender Youth
    Vin Tangpricha, MD, PhD
 
 
 
 

Treatment Options in Osteoporosis Across the Spectrum of Fracture Risk

Chair: Elaine W Yu, MD

  • Treatment Options for Individuals at Moderate Fracture Risk
    Ian Reid, FRACP
     
  • Transitions in Osteoporosis Pharmacotherapy
    Benjamin Z Leder, MD
     
  • Sclerostin Inhibition for the Treatment of Osteoporosis
    Suzanne M Jan De Beur, MD
 
 
 
 

How Do We Confront Disparities in Obesity and COVID-19 Treatment

Chair: Samuel Dagogo-Jack, MD, DSc

  • Environmental Determinants that Contribute to Racial/Ethnic Disparities in Obesity-Related Metabolic Risk Factors
    Rebecca E Hasson, PhD
     
  • Strategies for Reducing Obesity Disparities Through Policy
    Karen Glanz, PhD, MPH
     
  • Race/Ethnicity, Obesity, and COVID-19
    Monica Webb Hooper, PhD
 
 
 
 

Obesity in Youth and Adolescent: Treatment of a Growing Problem

  • Best Medical Practices in Obesity and Type 2 Diabetes Mellitus in Kids
    Seema Kumar, MD
     
  • The Last Resort or a Definitive Treatment: Bariatric Surgery in Adolescents
    Thomas Inge, MD, PhD
     
  • Pharmacotherapy for the Treatment of Adolescent Obesity: Where Are We Now? Where Are We Going?
    Ania M Jastreboff, MD, PhD
 

Post test How Can We Help? Feedback